Viatris Inc. (VTRS) Earnings Yield: N/A
The earnings yield for Viatris Inc. (VTRS) is N/A as of Sunday, June 21, 2026.
VTRS Earnings Yield Chart
VTRS Average Earnings Yield Chart
VTRS Earnings Yield Metrics
EARNINGS YIELD
N/A
EARNINGS YIELD AVG TTM
15.09%
EARNINGS YIELD AVG 3Y
8.72%
EARNINGS YIELD AVG 5Y
4.57%
EARNINGS YIELD AVG 10Y
2.91%
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
VTRS Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $17.90B | N/A | 15.09% | 8.72% | 4.57% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.02B | 4.38% | 4.29% | 3.81% | 2.97% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 3.16% | 3.63% | 3.48% | 5.61% |
| Incyte Corporation (INCY)vs › | $19.62B | 7.21% | 5.48% | 3.35% | 3.62% |
| Labcorp Holdings Inc. (LH)vs › | $20.98B | 4.41% | 3.73% | 3.33% | 6.03% |
| DaVita Inc. (DVA)vs › | $13.34B | 4.78% | 7.08% | 6.45% | 6.99% |
| Medpace Holdings, Inc. (MEDP)vs › | $13.14B | 3.46% | 3.04% | 3.12% | 3.13% |
| Solventum Corporation (SOLV)vs › | $13.06B | 10.83% | 8.25% | 8.18% | 8.18% |
| Align Technology, Inc. (ALGN)vs › | $13.04B | 3.27% | 3.52% | 2.68% | 2.49% |
| United Therapeutics Corporation (UTHR)vs › | $22.78B | 5.04% | 6.04% | 6.91% | 6.45% |
Earnings Yield vs P/E Ratio
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Viatris Inc. Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Viatris Inc. Earnings Yield FAQ
- What is the earnings yield for Viatris Inc. (VTRS)?
- The earnings yield for VTRS stock is N/A.
- What is the TTM average earnings yield for Viatris Inc. (VTRS)?
- The TTM average earnings yield for VTRS stock is 15.09%.
- What is the 3Y average earnings yield for Viatris Inc. (VTRS)?
- The 3Y average earnings yield for VTRS stock is 8.72%.
- What is the 5Y average earnings yield for Viatris Inc. (VTRS)?
- The 5Y average earnings yield for VTRS stock is 4.57%.
- What is the 10Y average earnings yield for Viatris Inc. (VTRS)?
- The 10Y average earnings yield for VTRS stock is 2.91%.
Viatris Inc. Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2024-05-08 | 0.34% |
| 2024-05-07 | 0.34% |
| 2024-05-06 | 0.34% |
| 2024-05-03 | 0.34% |
| 2024-05-02 | 0.34% |
| 2024-05-01 | 0.34% |
| 2024-04-30 | 0.35% |
| 2024-04-29 | 0.34% |
| 2024-04-26 | 0.35% |
| 2024-04-25 | 0.35% |
| 2024-04-24 | 0.35% |
| 2024-04-23 | 0.35% |
| 2024-04-22 | 0.36% |
| 2024-04-19 | 0.36% |
| 2024-04-18 | 0.36% |
| 2024-04-17 | 0.36% |
| 2024-04-16 | 0.36% |
| 2024-04-15 | 0.35% |
| 2024-04-12 | 0.35% |
| 2024-04-11 | 0.35% |
| 2024-04-10 | 0.34% |
| 2024-04-09 | 0.34% |
| 2024-04-08 | 0.34% |
| 2024-04-05 | 0.34% |
| 2024-04-04 | 0.34% |
| 2024-04-03 | 0.33% |
| 2024-04-02 | 0.34% |
| 2024-04-01 | 0.34% |
| 2024-03-28 | 0.34% |
| 2024-03-27 | 0.34% |
| 2024-03-26 | 0.34% |
| 2024-03-25 | 0.34% |
| 2024-03-22 | 0.34% |
| 2024-03-21 | 0.33% |
| 2024-03-20 | 0.34% |
| 2024-03-19 | 0.34% |
| 2024-03-18 | 0.34% |
| 2024-03-15 | 0.34% |
| 2024-03-14 | 0.34% |
| 2024-03-13 | 0.33% |
| 2024-03-12 | 0.33% |
| 2024-03-11 | 0.33% |
| 2024-03-08 | 0.33% |
| 2024-03-07 | 0.32% |
| 2024-03-06 | 0.33% |
| 2024-03-05 | 0.33% |
| 2024-03-04 | 0.32% |
| 2024-03-01 | 0.32% |
| 2024-02-29 | 0.32% |
| 2024-02-28 | 0.33% |
| 2024-02-27 | 0.30% |
| 2024-02-26 | 0.30% |
| 2024-02-23 | 11.16% |
| 2024-02-22 | 11.30% |
| 2024-02-21 | 11.39% |
| 2024-02-20 | 11.40% |
| 2024-02-16 | 11.56% |
| 2024-02-15 | 11.78% |
| 2024-02-14 | 12.52% |
| 2024-02-13 | 12.61% |
| 2024-02-12 | 12.64% |
| 2024-02-09 | 12.92% |
| 2024-02-08 | 13.05% |
| 2024-02-07 | 12.87% |
| 2024-02-06 | 12.71% |
| 2024-02-05 | 13.04% |
| 2024-02-02 | 12.74% |
| 2024-02-01 | 12.72% |
| 2024-01-31 | 12.84% |
| 2024-01-30 | 12.79% |
| 2024-01-29 | 12.71% |
| 2024-01-26 | 12.66% |
| 2024-01-25 | 12.87% |
| 2024-01-24 | 12.89% |
| 2024-01-23 | 12.84% |
| 2024-01-22 | 12.97% |
| 2024-01-19 | 13.25% |
| 2024-01-18 | 13.40% |
| 2024-01-17 | 13.18% |
| 2024-01-16 | 12.85% |
| 2024-01-12 | 12.92% |
| 2024-01-11 | 12.52% |
| 2024-01-10 | 12.48% |
| 2024-01-09 | 13.02% |
| 2024-01-08 | 12.90% |
| 2024-01-05 | 12.61% |
| 2024-01-04 | 13.07% |
| 2024-01-03 | 13.28% |
| 2024-01-02 | 13.26% |
| 2023-12-29 | 13.95% |
| 2023-12-28 | 13.91% |
| 2023-12-27 | 14.03% |
| 2023-12-26 | 14.10% |
| 2023-12-22 | 14.18% |
| 2023-12-21 | 14.18% |
| 2023-12-20 | 14.45% |
| 2023-12-19 | 14.53% |
| 2023-12-18 | 14.95% |
| 2023-12-15 | 14.71% |
| 2023-12-14 | 14.53% |
| 2023-12-13 | 14.90% |
| 2023-12-12 | 15.29% |
| 2023-12-11 | 15.36% |
| 2023-12-08 | 15.36% |
| 2023-12-07 | 15.48% |
| 2023-12-06 | 15.58% |
| 2023-12-05 | 15.72% |
| 2023-12-04 | 15.60% |
| 2023-12-01 | 16.10% |
| 2023-11-30 | 16.45% |
| 2023-11-29 | 16.53% |
| 2023-11-28 | 16.53% |
| 2023-11-27 | 16.16% |
| 2023-11-24 | 16.00% |
| 2023-11-22 | 16.10% |
| 2023-11-21 | 16.10% |
| 2023-11-20 | 15.95% |
| 2023-11-17 | 15.97% |
| 2023-11-16 | 16.47% |
| 2023-11-15 | 16.13% |
| 2023-11-14 | 16.37% |
| 2023-11-13 | 16.86% |
| 2023-11-10 | 16.42% |
| 2023-11-09 | 16.67% |
| 2023-11-08 | 16.37% |
| 2023-11-07 | 16.53% |
| 2023-11-06 | 16.61% |
| 2023-11-03 | 16.50% |
| 2023-11-02 | 17.12% |
| 2023-11-01 | 17.15% |
| 2023-10-31 | 17.18% |
| 2023-10-30 | 17.30% |
| 2023-10-27 | 17.45% |
| 2023-10-26 | 17.01% |
| 2023-10-25 | 17.06% |
| 2023-10-24 | 16.81% |
| 2023-10-23 | 17.15% |
| 2023-10-20 | 16.45% |
| 2023-10-19 | 16.45% |
| 2023-10-18 | 16.34% |
| 2023-10-17 | 16.23% |
| 2023-10-16 | 16.16% |
| 2023-10-13 | 16.39% |
| 2023-10-12 | 16.18% |
| 2023-10-11 | 15.80% |
| 2023-10-10 | 15.90% |
| 2023-10-09 | 15.85% |
| 2023-10-06 | 15.85% |
| 2023-10-05 | 15.80% |
| 2023-10-04 | 15.77% |
| 2023-10-03 | 15.85% |
| 2023-10-02 | 15.22% |
| 2023-09-29 | 15.53% |
| 2023-09-28 | 15.60% |
| 2023-09-27 | 15.95% |
| 2023-09-26 | 15.75% |
| 2023-09-25 | 15.75% |
| 2023-09-22 | 15.87% |
| 2023-09-21 | 15.80% |
| 2023-09-20 | 15.48% |
| 2023-09-19 | 15.48% |
| 2023-09-18 | 15.58% |
| 2023-09-15 | 15.65% |
| 2023-09-14 | 15.58% |
| 2023-09-13 | 15.70% |
| 2023-09-12 | 15.50% |
| 2023-09-11 | 15.29% |
| 2023-09-08 | 15.13% |
| 2023-09-07 | 15.29% |
| 2023-09-06 | 15.13% |
| 2023-09-05 | 14.41% |
| 2023-09-01 | 14.18% |
| 2023-08-31 | 14.22% |
| 2023-08-30 | 13.91% |
| 2023-08-29 | 13.91% |
| 2023-08-28 | 13.97% |
| 2023-08-25 | 13.95% |
| 2023-08-24 | 13.97% |
| 2023-08-23 | 13.91% |
| 2023-08-22 | 13.72% |
| 2023-08-21 | 13.61% |
| 2023-08-18 | 13.59% |
| 2023-08-17 | 13.50% |
| 2023-08-16 | 13.66% |
| 2023-08-15 | 13.72% |
| 2023-08-14 | 13.68% |
| 2023-08-11 | 13.48% |
| 2023-08-10 | 13.72% |
| 2023-08-09 | 13.59% |
| 2023-08-08 | 13.72% |
| 2023-08-07 | 13.91% |
| 2023-08-04 | 14.81% |
| 2023-08-03 | 15.02% |
| 2023-08-02 | 15.06% |
| 2023-08-01 | 15.36% |
| 2023-07-31 | 14.90% |
| 2023-07-28 | 15.11% |
| 2023-07-27 | 15.20% |
| 2023-07-26 | 14.97% |
| 2023-07-25 | 15.08% |
| 2023-07-24 | 14.79% |
| 2023-07-21 | 14.97% |
| 2023-07-20 | 14.99% |
| 2023-07-19 | 15.06% |
| 2023-07-18 | 15.43% |
| 2023-07-17 | 15.67% |
| 2023-07-14 | 15.46% |
| 2023-07-13 | 15.27% |
| 2023-07-12 | 15.34% |
| 2023-07-11 | 15.31% |
| 2023-07-10 | 15.82% |
| 2023-07-07 | 15.92% |
| 2023-07-06 | 15.95% |
| 2023-07-05 | 15.85% |
| 2023-07-03 | 15.87% |
| 2023-06-30 | 15.72% |
| 2023-06-29 | 15.85% |
| 2023-06-28 | 16.16% |
| 2023-06-27 | 15.95% |
| 2023-06-26 | 15.95% |
| 2023-06-23 | 16.08% |
| 2023-06-22 | 15.63% |
| 2023-06-21 | 15.53% |
| 2023-06-20 | 15.41% |
| 2023-06-16 | 15.27% |
| 2023-06-15 | 15.80% |
| 2023-06-14 | 16.08% |
| 2023-06-13 | 16.31% |
| 2023-06-12 | 16.69% |
| 2023-06-09 | 16.75% |
| 2023-06-08 | 16.50% |
| 2023-06-07 | 16.18% |
| 2023-06-06 | 16.50% |
| 2023-06-05 | 16.84% |
| 2023-06-02 | 16.84% |
| 2023-06-01 | 17.09% |
| 2023-05-31 | 17.15% |
| 2023-05-30 | 17.09% |
| 2023-05-26 | 17.24% |
| 2023-05-25 | 17.39% |
| 2023-05-24 | 17.39% |
| 2023-05-23 | 16.98% |
| 2023-05-22 | 16.58% |
| 2023-05-19 | 16.84% |
| 2023-05-18 | 16.75% |
| 2023-05-17 | 16.89% |
| 2023-05-16 | 17.15% |
| 2023-05-15 | 16.75% |
| 2023-05-12 | 16.92% |
| 2023-05-11 | 16.78% |
| 2023-05-10 | 16.37% |
| 2023-05-09 | 16.13% |
| 2023-05-08 | 16.00% |
| 2023-05-05 | 18.42% |
| 2023-05-04 | 18.98% |
| 2023-05-03 | 18.69% |
| 2023-05-02 | 18.76% |
| 2023-05-01 | 18.28% |
| 2023-04-28 | 18.32% |
| 2023-04-27 | 7.13% |
Showing the most recent 260 of 2,181 data points. The chart above shows the full history.
Related Metrics
About Viatris Inc.
Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors. Beyond manufacturing medicines, Viatris supports patient well-being through additional services such as diagnostic clinics, educational seminars, and digital tools designed to assist with health management. Products are made available in various forms, including oral solids, injectable solutions, complex dosage formulations, and raw APIs. Viatris distributes these to a broad clientele globally, including retail pharmacies, wholesalers, government bodies, insurance providers, and institutional healthcare facilities. The distribution network involves pharmaceutical wholesalers, retail and institutional pharmacies, mail-order and e-commerce platforms, and specialty pharmacies. The company's extensive portfolio includes prominent brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, Yupelri, Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV. Its biosimilar franchises feature products such as Fulphila, Ogivri, Hulio, and SEMGLEE. Viatris Inc. also fosters innovation through strategic collaborations and licensing agreements with partners including Revance Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Theravance Biopharma, Inc., Biocon Ltd., and Fujifilm Kyowa Kirin Biologics Co. Ltd. Founded in 1961, Viatris Inc. maintains its corporate headquarters in Canonsburg, Pennsylvania.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Scott Andrew Smith